Shwachman-diamond syndrome: how not to miss a serious illness
https://doi.org/10.31146/1682-8658-ecg-221-1-173-176
Abstract
Shwachman-Diamond syndrome is a rare disease inherited by autosomal recessive type, characterized by exocrine pancreatic insufficiency, bone abnormalities, growth retardation, bone marrow insufficiency with an increased risk of developing myelodysplastic syndrome and acute myeloblastic leukemia. The clinical manifestation of the disease is observed at the neonatal age. Pathology requires lifelong enzyme replacement therapy. The article contains a retrospective analysis of four case histories of children with Shwachman-Diamond syndrome. These clinical cases illustrate the importance of timely diagnosis and treatment of the disease. Early diagnosis and prescription of optimal enzyme replacement therapy contributes to adequate physical development of the child, improving his quality of life and prognosis.
About the Authors
N. V. Nikolaeva
Russian National Research Medical University named after. N.I. Pirogov
Russian Federation
Russian Federation
M. L. Babayan
Russian National Research Medical University named after. N.I. Pirogov
Russian Federation
Russian Federation
L. A. Kharitonova
Russian National Research Medical University named after. N.I. Pirogov
Russian Federation
Russian Federation
References
1. Nelson A.S., Myers K.C. Diagnosis, treatment, and Molecular Pathology of Shwachman-Diamond Syndrome. Hematol Oncol Clin North Am. 2018;32(4):687-700.
2. Myers K.C., Furutani E., Weller E., Siegele B., Galvin A., Arsenault V. et al. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. Lancet Haematol. 2020;7(3):e238-46.
3. Furutani E., Liu S., Galvin A., Steltz S., Malsch M.M., Loveless S.K. et al. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Adv. 2022;6(1):297-306.
4. Goobie S., Popovic M., Morrison J., et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am. J. Hum. Genet. 2001; 68: 1048-1054.
5. Kallen M.E., Dulau-Florea A., Wang W., Calvo K.R. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications. Semin Hematol. 2019 Jan;56(1):69-82.
6. Steele L., Rommens J.M., Stockley T., Baskin B., Ray P.N. De Novo Mutations Causing Shwachman-Diamond Syndrome and a Founder Mutation in SBDS in the French Canadian Population. J. Investig. Genomics. 2014; 1 (2): 00008.
7. Yigal Dror, Jean Donadieu, Jutta Koglmeier et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome Ann. N.Y. Acad. Sci. 2011; 1242: 40-55
8. Lesesve J.F., Dugue F., Gregoire M.J. et al. ShwachmanDiamond syndrome with late-onset neutropenia and fatal acute myeloid leukaemia without maturation: a case report. Eur J Haematol. 2003;71(5):393-395. doi: 10.1034/j.1600-0609. 2003.00146.x.
9. Makitie O., Ellis L., Durie P.R. et al. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet. 2004;65(2):101-112. doi: 10.1111/j.0009- 9163.2004.00198.x.
Review
For citations:
Nikolaeva N.V., Babayan M.L., Kharitonova L.A. Shwachman-diamond syndrome: how not to miss a serious illness. Experimental and Clinical Gastroenterology. 2024;(1):173-176. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-221-1-173-176
Views:
207
Email this article 